V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20160026 | 20061579 | 1.66 | 110 | Curative (C) | 2017-10-09 | 2017-10-16 | ECX | 02 | null | ECX | 101558557 |
| 20160028 | 20061580 | 1.57 | 99.7 | Neo-adjuvant (N) | 2020-01-22 | 2020-01-24 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100686325 |
| 20160031 | 20061581 | 1.83 | 97.2 | Neo-adjuvant (N) | 2020-08-11 | 2020-08-18 | ECX | N | N | ECX | 100411670 |
| 20160033 | 20061582 | 1.66 | 76.1 | null | 2016-09-27 | 2016-10-04 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101230469 |
| 20160034 | 20061583 | 1.64 | 82.85 | Palliative (P) | 2017-02-28 | 2017-03-27 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101218624 |
| 20160035 | 20061584 | 1.69 | 140 | Palliative (P) | 2016-10-13 | 2016-10-14 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100350866 |
| 20160037 | 20061585 | 1.61 | 57 | Neo-adjuvant (N) | 2019-10-27 | 2019-11-18 | ECX | N | N | ECX | 100902548 |
| 20160039 | 20061586 | 1.69 | 69.7 | Palliative (P) | 2019-06-16 | 2019-07-09 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101829589 |
| 20160040 | 20061587 | 1.67 | 51.8 | Palliative (P) | 2018-03-11 | 2018-03-17 | ECX | null | null | ECX | 100420411 |
| 20160041 | 20061588 | 1.55 | 108 | Palliative (P) | 2018-01-28 | 2018-02-22 | Gemcitabine + Capecitabine | null | N | CAPECITABINE + GEMCITABINE | 101748838 |
| 20160042 | 20061589 | 1.5 | 70.5 | Neo-adjuvant (N) | 2019-07-09 | 2019-07-23 | ECX | N | N | ECX | 100896284 |
| 20160045 | 20061590 | 1.57 | 70.4 | Neo-adjuvant (N) | 2019-01-14 | 2019-01-18 | ECX | 02 | N | ECX | 100067852 |
| 20160050 | 20061591 | 1.83 | 68.8 | Neo-adjuvant (N) | 2016-03-27 | 2016-04-09 | ECX | N | N | ECX | 101173438 |
| 20160051 | 20061592 | 1.62 | 58 | Palliative (P) | 2016-03-18 | 2016-03-28 | ECX | 02 | N | ECX | 100231265 |
| 20160053 | 20061593 | 1.64 | 59.9 | Curative (C) | 2016-10-19 | 2016-11-10 | ECX | 02 | N | ECX | 100688332 |
| 20160054 | 20061594 | null | 44.4 | Neo-adjuvant (N) | 2017-04-30 | 2017-04-30 | ECX | N | null | ECX | 100278399 |
| 20160056 | 20061595 | 1.78 | 103.9 | Neo-adjuvant (N) | 2019-11-24 | 2019-12-10 | ECX | N | N | ECX | 100455536 |
| 20160059 | 20061596 | 1.47 | 78.3 | Curative (C) | 2017-02-21 | 2017-03-04 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100019801 |
| 20160060 | 20061597 | 1.91 | 101.2 | Adjuvant (A) | 2017-06-28 | 2017-07-12 | CAPECITABINE + GEMCITABINE | 2 | null | CAPECITABINE + GEMCITABINE | 100938149 |
| 20160061 | 20061598 | 1.73 | 83.6 | Neo-adjuvant (N) | 2018-08-30 | 2018-08-30 | ECX | N | N | ECX | 100008916 |
| 20160062 | 20061599 | 1.74 | 55.8 | Adjuvant (A) | 2018-02-20 | 2018-03-06 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100617172 |
| 20160063 | 20061600 | 1.7 | 76.8 | Neo-adjuvant (N) | 2016-09-26 | 2016-09-26 | ECX | N | N | ECX | 101211240 |
| 20160065 | 20061601 | 1.58 | 73 | Curative (C) | 2018-08-21 | 2018-08-24 | ECX | null | N | ECX | 100696596 |
| 20160069 | 20061602 | 1.76 | 58.4 | Neo-adjuvant (N) | 2017-06-07 | 2017-06-21 | ECX | N | N | ECX | 101114384 |
| 20160071 | 20061603 | 1.79 | 53 | Neo-adjuvant (N) | 2019-11-07 | 2019-11-16 | ECX | N | null | CAPECITABINE + GEMCITABINE | 100298691 |
| 20160072 | 20061604 | 1.78 | 92.6 | Curative (C) | 2016-02-15 | 2016-02-18 | ECX | N | N | ECX | 100316705 |
| 20160073 | 20061605 | 1.65 | 63 | null | 2016-06-12 | 2016-06-15 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100802073 |
| 20160074 | 20061606 | 1.66 | 77 | Adjuvant (A) | 2016-11-27 | 2016-11-27 | Gemcitabine + Capecitabine | N | null | CAPECITABINE + GEMCITABINE | 100462712 |
| 20160076 | 20061607 | 1.75 | 66.2 | Palliative (P) | 2019-02-17 | 2019-03-02 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101459796 |
| 20160077 | 20061608 | 1.58 | 60.3 | Palliative (P) | 2019-03-12 | 2019-03-26 | ECX | N | N | CAPECITABINE + GEMCITABINE | 100954952 |
| 20160078 | 20061609 | 1.5 | 61.5 | Adjuvant (A) | 2018-06-14 | 2018-06-16 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100511493 |
| 20160080 | 20061610 | 1.77 | 67 | Palliative (P) | 2018-01-13 | 2018-02-02 | ECX | 02 | N | ECX | 101015704 |
| 20160081 | 20061611 | 1.8 | 79.4 | Neo-adjuvant (N) | 2016-04-11 | 2016-04-16 | ECX | 02 | N | ECX | 101210879 |
| 20160082 | 20061612 | 1.72 | 68 | Neo-adjuvant (N) | 2016-10-15 | 2016-10-27 | ECX | 02 | null | ECX | 101576264 |
| 20160084 | 20061613 | 1.69 | 55.7 | Palliative (P) | 2018-05-11 | 2018-05-18 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101223140 |
| 20160085 | 20061614 | 1.71 | 74 | Palliative (P) | 2016-09-28 | 2016-10-10 | ECX | 02 | N | ECX | 100586396 |
| 20160086 | 20061615 | 1.62 | 52.05 | Adjuvant (A) | 2017-04-19 | 2017-04-24 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101722745 |
| 20160087 | 20061616 | null | null | Palliative (P) | 2016-12-12 | 2016-12-12 | CAPECITABINE + GEMCITABINE | Y | N | CAPECITABINE + GEMCITABINE | 101165252 |
| 20160091 | 20061617 | 1.63 | 82 | Palliative (P) | null | 2019-04-04 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 100143586 |
| 20160092 | 20061618 | 1.5 | 82 | Neo-adjuvant (N) | 2017-04-01 | 2017-04-08 | ECX | N | N | ECX | 100777666 |
| 20160094 | 20061619 | 1.75 | 86 | Adjuvant (A) | 2018-05-17 | 2018-05-28 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100948810 |
| 20160095 | 20061620 | 1.7 | 79.4 | Adjuvant (A) | 2019-05-26 | 2019-06-26 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100999280 |
| 20160096 | 20061621 | 1.65 | null | Palliative (P) | 2017-12-01 | 2017-12-01 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101756143 |
| 20160102 | 20061622 | 1.69 | 61.7 | Neo-adjuvant (N) | 2017-11-11 | 2017-11-24 | ECX | 02 | N | ECX | 100166080 |
| 20160104 | 20061623 | 1.66 | 53.35 | Neo-adjuvant (N) | 2016-02-19 | 2016-02-19 | ECX | 02 | N | ECX | 100803207 |
| 20160107 | 20061624 | 1.73 | 79.4 | Palliative (P) | 2019-11-15 | 2019-12-03 | ECX | 02 | N | ECX | 100323356 |
| 20160111 | 20061625 | 1.81 | 96 | null | 2019-04-14 | 2019-04-30 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101756257 |
| 20160112 | 20061626 | 1.78 | 110 | Neo-adjuvant (N) | 2019-07-08 | 2019-07-08 | ECX | N | N | ECX | 100755437 |
| 20160113 | 20061627 | 1.67 | 98.2 | Palliative (P) | 2017-10-09 | 2017-10-10 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100516625 |
| 20160114 | 20061628 | 1.77 | 94 | Palliative (P) | 2018-01-06 | 2018-01-19 | ECX | N | N | ECX | 100297381 |